pmid,title,journal,year,drug,disease
40868984,Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection.,International journal of molecular sciences,2025,Lisinopril,Malaria
39070798,Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.,Frontiers in pharmacology,2024,Lisinopril,Malaria
35359831,"Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice.",Frontiers in pharmacology,2022,Lisinopril,Malaria
17235418,Gateways to clinical trials.,Methods and findings in experimental and clinical pharmacology,2006,Lisinopril,Malaria
